CSNpharm
Ambroxol is a secretolytic agent used in the treatment of respiratory diseases associated with viscid or excessive mucus.
More Information
Supplier Page
CSNpharm
Ambroxol HCl is an inhibitor of neuronal Na+ channels. It inhibits TTX-resistant and sensitive Na+ currents with IC50 of 35.2 μM (tonic)/22.5 μM (phasic block) and 100 μM, respectively.
More Information
Supplier Page
CSNpharm
Ambroxol HCl is an inhibitor of neuronal Na+ channels. It inhibits TTX-resistant and sensitive Na+ currents with IC50 of 35.2 μM (tonic)/22.5 μM (phasic block) and 100 μM, respectively.
More Information
Supplier Page
CSNpharm
Amentoflavone is an inhibitor of human UDP-glucuronosyltransferases with anti-inflammatory, antioxidative, and neuroprotective effects and it can be isolated from the seeds of Ginkgo biloba L. Amentoflavone inhibited SARS-CoV 3CL(pro) with IC50 value of 8.3μM.
More Information
Supplier Page
CSNpharm
Amentoflavone is an inhibitor of human UDP-glucuronosyltransferases with anti-inflammatory, antioxidative, and neuroprotective effects and it can be isolated from the seeds of Ginkgo biloba L. Amentoflavone inhibited SARS-CoV 3CL(pro) with IC50 value of 8.3μM.
More Information
Supplier Page
CSNpharm
Amentoflavone is an inhibitor of human UDP-glucuronosyltransferases with anti-inflammatory, antioxidative, and neuroprotective effects and it can be isolated from the seeds of Ginkgo biloba L. Amentoflavone inhibited SARS-CoV 3CL(pro) with IC50 value of 8.3μM.
More Information
Supplier Page
CSNpharm
Amentoflavone is an inhibitor of human UDP-glucuronosyltransferases with anti-inflammatory, antioxidative, and neuroprotective effects and it can be isolated from the seeds of Ginkgo biloba L. Amentoflavone inhibited SARS-CoV 3CL(pro) with IC50 value of 8.3μM.
More Information
Supplier Page
CSNpharm
Amentoflavone is an inhibitor of human UDP-glucuronosyltransferases with anti-inflammatory, antioxidative, and neuroprotective effects and it can be isolated from the seeds of Ginkgo biloba L. Amentoflavone inhibited SARS-CoV 3CL(pro) with IC50 value of 8.3μM.
More Information
Supplier Page
CSNpharm
Amezinium methylsulfate can stimulate α and β-1 receptors and inhibit noradrenaline and tyramine uptake, used as a sympathomimetic drug for the treatment of low blood pressure.
More Information
Supplier Page
CSNpharm
Amezinium methylsulfate can stimulate α and β-1 receptors and inhibit noradrenaline and tyramine uptake, used as a sympathomimetic drug for the treatment of low blood pressure.
More Information
Supplier Page
CSNpharm
Amezinium methylsulfate can stimulate α and β-1 receptors and inhibit noradrenaline and tyramine uptake, used as a sympathomimetic drug for the treatment of low blood pressure.
More Information
Supplier Page
CSNpharm
Amfenac Sodium Monohydrate is a non-steroidal analgesic anti-inflammatory drug with acetic acid moiety. The IC50 values for COX1 and COX2 is 250 nM and 150 nM, respectively.
More Information
Supplier Page
CSNpharm
Amfenac Sodium Monohydrate is a non-steroidal analgesic anti-inflammatory drug with acetic acid moiety. The IC50 values for COX1 and COX2 is 250 nM and 150 nM, respectively.
More Information
Supplier Page
CSNpharm
AMG-487 is a small molecule antagonist of the chemokine receptor CXCR3 and inhibits binding of 125I-IP-10 and 125I-ITAC to CXCR3.
More Information
Supplier Page
CSNpharm
AMG-487 is a small molecule antagonist of the chemokine receptor CXCR3 and inhibits binding of 125I-IP-10 and 125I-ITAC to CXCR3.
More Information
Supplier Page
CSNpharm
AMG-487 is a small molecule antagonist of the chemokine receptor CXCR3 and inhibits binding of 125I-IP-10 and 125I-ITAC to CXCR3.
More Information
Supplier Page
CSNpharm
AMG-487 is a small molecule antagonist of the chemokine receptor CXCR3 and inhibits binding of 125I-IP-10 and 125I-ITAC to CXCR3.
More Information
Supplier Page
CSNpharm
AMG-487 is a small molecule antagonist of the chemokine receptor CXCR3 and inhibits binding of 125I-IP-10 and 125I-ITAC to CXCR3.
More Information
Supplier Page
CSNpharm
AMG-487 is a small molecule antagonist of the chemokine receptor CXCR3 and inhibits binding of 125I-IP-10 and 125I-ITAC to CXCR3.
More Information
Supplier Page
CSNpharm
AMG-900 is a potent and highly selective pan-Aurora kinases inhibitor for Aurora A/B/C with IC50 of 5 nM/4 nM /1 nM, and is > 10-fold selective for Aurora kinases than p38α, Tyk2, JNK2, Met and Tie2.
More Information
Supplier Page
CSNpharm
AMG-900 is a potent and highly selective pan-Aurora kinases inhibitor for Aurora A/B/C with IC50 of 5 nM/4 nM /1 nM, and is > 10-fold selective for Aurora kinases than p38α, Tyk2, JNK2, Met and Tie2.
More Information
Supplier Page
CSNpharm
AMG-900 is a potent and highly selective pan-Aurora kinases inhibitor for Aurora A/B/C with IC50 of 5 nM/4 nM /1 nM, and is > 10-fold selective for Aurora kinases than p38α, Tyk2, JNK2, Met and Tie2.
More Information
Supplier Page
CSNpharm
AMG-900 is a potent and highly selective pan-Aurora kinases inhibitor for Aurora A/B/C with IC50 of 5 nM/4 nM /1 nM, and is > 10-fold selective for Aurora kinases than p38α, Tyk2, JNK2, Met and Tie2.
More Information
Supplier Page
CSNpharm
AMG-900 is a potent and highly selective pan-Aurora kinases inhibitor for Aurora A/B/C with IC50 of 5 nM/4 nM /1 nM, and is > 10-fold selective for Aurora kinases than p38α, Tyk2, JNK2, Met and Tie2.
More Information
Supplier Page
AMI-1
10mg
| ≥99%
CSNpharm
AMI-1 is an inhibitor of protein arginine N-methyltransferases (PRMTs) with IC50 of 8.8 μM for PRMT1 via blocking peptide-substrate binding.
More Information
Supplier Page
AMI-1
25mg
| ≥99%
CSNpharm
AMI-1 is an inhibitor of protein arginine N-methyltransferases (PRMTs) with IC50 of 8.8 μM for PRMT1 via blocking peptide-substrate binding.
More Information
Supplier Page
AMI-1
1mg
| ≥99%
CSNpharm
AMI-1 is an inhibitor of protein arginine N-methyltransferases (PRMTs) with IC50 of 8.8 μM for PRMT1 via blocking peptide-substrate binding.
More Information
Supplier Page
AMI-1
5mg
| ≥99%
CSNpharm
AMI-1 is an inhibitor of protein arginine N-methyltransferases (PRMTs) with IC50 of 8.8 μM for PRMT1 via blocking peptide-substrate binding.
More Information
Supplier Page
CSNpharm
AMI-1 free acid is a potent, cell-permeable and reversible inhibitor of protein arginine N-methyltransferases (PRMTs), with IC50s of 8.8 μM and 3.0 μM for human PRMT1 and yeast-Hmt1p, respectively. AMI-1 free acid exerts PRMTs inhibitory effects by blocking peptide-substrate binding.
More Information
Supplier Page
CSNpharm
Amifampridine is a quaternary ammonium compound that blocks presynaptic potassium channels, subsequently prolongs the action potential and increases presynaptic calcium concentrations, it was approved by the US FDA for the treatment of adults with LEMS.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Amifostine is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents.
More Information
Supplier Page
CSNpharm
Amifostine is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents.
More Information
Supplier Page
CSNpharm
Amifostine is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents.
More Information
Supplier Page
CSNpharm
Amifostine 3H2O is an approved radiation-protective agent and also a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents.
More Information
Supplier Page
CSNpharm
Amifostine 3H2O is an approved radiation-protective agent and also a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents.
More Information
Supplier Page
CSNpharm
Amifostine 3H2O is an approved radiation-protective agent and also a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents.
More Information
Supplier Page
CSNpharm
Amifostine 3H2O is an approved radiation-protective agent and also a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents.
More Information
Supplier Page
CSNpharm
Amikacin Disulfateis is an antibiotic used for a number of bacterial infections, including joint infections, intra-abdominal infections, meningitis, pneumonia, sepsis, and urinary tract infections, and treatment of multidrug-resistant tuberculosis.
More Information
Supplier Page
CSNpharm
Amikacin Disulfateis is an antibiotic used for a number of bacterial infections, including joint infections, intra-abdominal infections, meningitis, pneumonia, sepsis, and urinary tract infections, and treatment of multidrug-resistant tuberculosis.
More Information
Supplier Page
CSNpharm
Amikacin sulfate (BAY 41-6551 sulfate) is an aminoglycoside antibiotic and a semisynthetic analog of kanamycin. Amikacin sulfate is bactericidal, acting directly on the 30S and 50S bacerial ribosomal subunits to inhibit protein synthesis. Amikacin sulfate is very active against most Gram-negative bacteria including gentamicin- and tobramycin-resistant strains. Amikacin sulfate also inhibits the infections caused by […]
More Information
Supplier Page
CSNpharm
Amino-PEG4-alcohol is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Amino-PEG4-alcohol is also a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
Aminohippurate sodium is a diagnostic agent useful in medical tests involving the kidney used in the measurement of renal plasma flow.
More Information
Supplier Page
CSNpharm
Aminohippurate sodium is a diagnostic agent useful in medical tests involving the kidney used in the measurement of renal plasma flow.
More Information
Supplier Page
CSNpharm
Aminomalonic acid is an amino endogenous metabolite, acts as a strong inhibitor of L-asparagine synthetase from Leukemia 5178Y/AR (Ki= 0.0023 M) and mouse pancreas (Ki= 0.0015 M) in vitro. Aminomalonic acid is a potential biomarker to discriminate between different stages of melanoma metastasis.
More Information
Supplier Page
